Interleukin-9 and mast cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 3, 2012, Pages 319-326

  Tete S ^a   Nicoletti, M ^a   Sagginp, A ^b   Maccauro, G ^c   Rosati, M ^d   Conti, F ^d   Cianchetti, E ^a   Tripodi, D ^a   Toniato, E ^a   Fulcheri, M ^a   Salini, V ^a   Caraffa, A ^e   Antinolfi, P ^e   Frydas, S ^f   Pandolfi, F ^c   Conti, P ^a   Potalivo, G ^g   Theoharides, T C ^h  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Pescara Hospital   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f Veterinary School   (Greece)

^g Nicola's Foundation   (Italy)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; IL 9; Inflammation; Mast cells

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA;

B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; HUMAN; INNATE IMMUNITY; MAST CELL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; REVIEW; T LYMPHOCYTE; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-9; MAST CELLS; RESPIRATORY HYPERSENSITIVITY;

BACTERIA (MICROORGANISMS);

EID: 84868122384     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Mekori YA Metcalfe DD. Mast cells in innate immunity. Immunol Rev 2000; 173:131-40. (Pubitemid 30095217)
2. Di Muzio G, Perricone C, Ballanti E, et al. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment. Int J Immunopathol Pharmacol 2011; 24:357-66.
3. Colombo C, Faelli N, Tirelli AS, et al. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multiparametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol 2011; 24:423-32.
4. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000; 12:624-31.
5. Marzano AV, Cugno M, Trevisan V, Lazzari R, Fanoni D, Berti E, Crosti C. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses. Int J Immunopathol Pharmacol 2011; 24:451-60.
6. Nisticò R, Mehdawy B, Piccirilli S, Mercuri N. Paraquat- and rotenone-induced models of Parkinson's disease. Int J Immunopathol Pharmacol 2011; 24:313-22.
7. Belloli L, Carlo-Stella N, Ughi N, Marasini B. Cancer in Italian patients with systemic sclerosis. Eur J Inflamm 2011; 9:151-6.
8. Mirzaei K, Hossein-Nezhad A, Mokhtari F, Najmafshar A, Khoshniat Nikoo M. VISFATIN/NAMPT/PBCEF and cytokine concentration in multiple sclerosis patients compared to healthy subjects. Eur J Inflamm 2011; 9:31-37.
9. Cantarini L, Iacoponi F, Lucherini OM, et al. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. Int J Immunopathol Pharmacol 2011; 24:695-702.
10. Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004; 20:381-92 (Pubitemid 38482117)
11. Scaparrotta A, Verrotti A, Consilvio NP, Cingolani A, Di Pillo S, Di Gioacchino M, Verini M, Chiarelli F. Pathogenesis and clinical approaches to anticonvulsant hypersensitivity syndrome: current state of knowledge. Int J Immunopathol Pharmacol 2011; 24:277-84.
12. Rivetti S, Lauriola M, Voltattorni M, et al. Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. Int J Immunopathol Pharmacol 2011; 24:639-49.
13. Saggini A, Tripodi D, Maccauro G, et al. Tumor necrosis factor-alpha and mast cells: revisited study. Eur J Inflamm 2011; 9:17-22.
14. Aslani S, Hossein-Nezhad A, Mirzaei K, Maghbooli Z, Asgarabad SN, Karimi F. Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict gestational diabetes mellitus severity. Eur J Inflamm 2011; 9:193-7.
15. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood 1997; 89:2654-63. (Pubitemid 27172549)
16. Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol 2011; 24:15-23.
17. Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. A pilot study evaluating the clinical and immunomodulatory effects of an orally administered extract of Dendrobium huoshanense in children with moderate to severe recalcitrant atopic dermatitis. Int J Immunopathol Pharmacol 2011; 24:367-75.
18. Sancilio S, Di Giacomo V, Quaglietta AM, et al. TRAIL promotes a pro-survival signal in erythropoietin-deprived human erythroblasts through the activation of an NF-κB/IκBα pathway. J Biol Regul Homeost Agents 2011; 25:375-386.
19. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends in Pharmacol Sci 2004; 25: 563-8 (Pubitemid 39371146)
20. Nenna R, Papoff P, Moretti C, et al. Detection of respiratory viruses in the 2009 winter season in Rome: 2009 influenza A (H1N1) complications in children and concomitant type 1 diabetes onset. Int J Immunopathol Pharmacol 2011; 24:651-9.
21. Drago L, Vassena C, Dozio E, Corsi MM, De Vecchi E, Mattina R, Romanò C. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int J Immunopathol Pharmacol 2011; 24:433-40.
22. Nakanishi K. Basophils are potent antigen-presenting cells that selectively induce Th2 cells. Eur J Immunol 2010; 40:1836-42.
23. Pollice R, Bianchini V, Marola V, et al. Post-traumatic and psychiatric symptoms among young earthquake survivors in primary care camp hospital. Eur J Inflamm 2011; 9:39-44.
24. Obara W, Kawa Y Ra C, Nishioka K, Soma Y, Mizoguchi M. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 2002; 205:11-17. (Pubitemid 36152955)
25. Artini M, Scoarughi GL, Papa R, et al. A new anti-infective strategy to reduce adhesion-mediated virulence in Staphylococcus aureus affecting surface proteins. Int J Immunopathol Pharmacol 2011; 24:661-72.
26. Sakellaropoulou AV, Hatzistilianou MN, Emporiadou MN, Aivazis VT, Rousso I, Athanasiadou-Piperopoulou F. Evaluation of thyroid gland function in children with obstructive apnea hypopnea syndrome. Int J Immunopathol Pharmacol 2011; 24:377-86.
27. Di Paola R, Mazzon E, Paterniti I, Impellizzeri D, Bramanti P, Cuzzocrea S. Apocynin, a plant-derived drug, might be useful in the treatment of myocardial ischemia reperfusion injury in rat hearts. Eur J Inflamm 2011; 9:169-74.
28. Zhu J-S, Xu Z-P, Song M-Q, Zhang Q. Effect of oxymatrine combined with low dose 5-FU on lymphatic vessel and microvascular endothelial cell growth of gastric cancer in a severe combined immunodeficient mouse orthotopic implantation model. Eur J Inflamm 2011; 9:45-51.
29. Schmitt E, Germann T, Goedert S, et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994;153:3989-96.
30. Losi M, Bocchino M, Matarese A, et al. Role of the quantiferon-TB test in ruling out pleural tuberculosis: a multi-centre study. Int J Immunopathol Pharmacol 2011; 24:159-65.
31. Iezzi M, Quaglino E, Cappello P, et al. HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. Int J Immunopathol Pharmacol 2011; 24:621-30.
32. Carlesimo M, Narcisi A, Cortesi G, Mari E, Fidanza L, De Marco G, Rossi A, Camplone G. An 18-year follow-up of a case of D-penicillamine-induced Elastosis perforans serpiginosa. Int J Immunopathol Pharmacol 201l;24(1):257-9.
33. Saggini A, Anogeianaki A, Maccauro G, Teté S, Salini V, Caraffa A, Conti P, Shaik-Dasthagirisaheb YB. What you should know about Escherichia coli infection. Eur J Inflamm 2011; 9:103-6.
34. Maghbooli Z, Hossein-Nezhad A, Shirzad M, Behzadi H. The role of osteoprotegrin/ nuclear factor kb ligand in coronary collateral development Eur J Inflamm 2011; 9:57-64.
35. Merz H, Kaehler C, Hoefig KP, et al. Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice. Oncotarget 2010; 1:104-19.
36. Racciatti D, Gorgoretti V, Sepede G, Gambi F, Pizzigallo E. An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences. Int J Immunopathol Pharmacol 2011; 24:673-81.
37. Palumbo P, Cinque B, Miconi G, et al. Biological effects of low frequency high intensity ultrasound application on ex vivo human adipose tissue. Int J Immunopathol Pharmacol 2011; 24:411-22.
38. Pierangeli A, Degener AM, Ferreri ML, et al. Interferon-induced gene expression in cervical mucosa during human papillomavirus infection. Int J Immunopathol Pharmacol 2011; 24:217-23.
39. Tsoucalas G, Karamanou M, Androutsos G. Travelling through time with aspirin, a healing companion. Eur J Inflamm 2011; 9:13-16.
40. Ciprandi G, De Amici M, Quaglini S, et al. Prediction of allergy by total serum IgE measurements in infancy: a 10-year follow-up. Eur J Inflamm 2011; 9:199-203.
41. Noelle RJ, Nowak EC. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010; 10:683-7.
42. Sharma JN, Kesavarao U. The effects of Captopril on cardiac regression, blood pressure and bradykinin components in diabetic Wistar Kyoto rats. Int J Immunopathol Pharmacol 2011; 24:337-43.
43. Almerigogna F, Fassio F, Giudizi MG, et al. Natural killer cell deficiencies in a consecutive series of children with herpetic encephalitis. Int J Immunopathol Pharmacol 2011; 24:231-8.
44. Mazzoccoli G, Carughi S, Sperandeo M, Pazienza V, Giuliani F, Tarquini R. Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans. J Biol Regul Homeost Agents 2011; 25:249-57.
45. Migueres M, Fontaine JF, Haddad T, Grosclaude M, Saint-Martin F, Bem David D, Crestani B. Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (REALIS). Int J Immunopathol Pharmacol 2011; 24:387-400.
46. Stephens GL, Swerdlow B, Benjamin E, Coyle AJ, Humbles A, Kolbeck R, Fung M. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. Eur J Immunol 2011; 4:952-62.
47. Shi Q, Gao ZY, Xie F, et al. A novel monoclonal antibody against human CD80 and its immune protection in a mouse lupus-like disease. Int J Immunopathol Pharmacol 2011; 24:583-93.
48. Marchisio P, Bianchini S, Galeone C, et al. Use of complementary and alternative medicine in children with recurrent acute otitis media in Italy. Int J Immunopathol Pharmacol 2011; 24:441-9.
49. Ciprandi G, De Amici M, Berardi L, Vignini M, Marseglia G. Serum IgE for Bet v 1 in patients affected by atopic dermatitis. Eur J Inflamm 2011; 9:205-7.
50. Failli A, Legitimo A, Mazzoni A, Urbani L, Scatena F, Mosca F, Consolini R. The combination of immunosuppressive drugs with 8-methoxypsoralen and ultraviolet a light modulates the myeloid-derived dendritic cell function. Int J Immunopathol Pharmacol 2011; 24:89-99.
51. Binici DN, Güneş N, Kayataş K, Pişkinpaş a N. The effects of interferon-α2b on intestinal flora in peritoneal fibrosis. Eur J Inflamm 2011; 9:135-139.
52. Jones TG, Hallgren J, Humbles A, Burwell T, Finkelman FD, Alcaide P, Austen KF, Gurish MF. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol 2009; 183:5251-60.
53. Tsoupras AB, Chini M, Tsogas N, Mangaras N, Demopoulos CA, Lazanas MC. In vivo effects of a Ginkgo biloba extract on platelet activating factor metabolism in two asymptomatic HIV-infected patients. Eur J Inflamm 2011; 9:107-16.
54. Bellisai F, Morozzi G, Scaccia F, Chellini F, Simpatico A, Pecetti G, Galeazzi M. Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis. Int J Immunopathol Pharmacol 2011; 24(1):261-4.
55. Tammaro A, Narcisi A, Persechino S, De Marco G, Camplone G. Contact allergy to disperse blue dye in goggles for swimming-bath. Eur J Inflamm 2011; 9:83-84.
56. Steenwinckel V, Louahed J, Lemaire MM, et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 2009; 182:4737-43.
57. Veda P. Why are neutrophils polymorphonuclear? Eur J Inflamm 2011; 9:85-93.
58. Li XF, Guo YJ, Wang ML,et al. Inducing-apoptotic activity of the ethanol extract of Duchesnea indica Focke on treatment of herpes simplex encephalitis. Int J Immunopathol Pharmacol 2011; 24:631-8.
59. Salini V, Conti P. Inflammatory markers: serum amyloid A, fibrinogen and C-reactive protein - a revisited study. Eur J Inflamm 2011; 9:95-102.
60. Giganti MG, Minella D, Testa B, et al. A pilot study on the transcriptional response of androgen- and insulin-related genes in peripheral blood mononuclear cells induced by testosterone administration in hypogonadal men. J Biol Regul Homeost Agents 2011; 25:291-4.
61. Nouri-Aria KT, Pilette C, Jacobson MR, Watanabe H, Durham SR. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 2005; 116:73-9. (Pubitemid 40909751)
62. Tremolada S, Delbue S, Ferraresso M, Carloni C, Elia F, Larocca S, Bortolani E, Ferrante P. Search for genomic sequences of microbial agents in atherosclerotic plaques. Int J Immunopathol Pharmacol 2011;24(1):243-6.
63. Symeonidou I, Hatzistilianou M, Papadopoulos E, et al . Susceptibility and resistance to canine leishmaniosis is associated to polymorphisms of the canine TNF-α gene. Eur J Inflamm 2011; 9:23-29.
64. Gallenga PE, Del Boccio M, Rapinese M, Di Iorio A, Toniato E, Martinotti S. Molecular approach by PCR is the best method to detect the presence of Chlamydia trachomatis and to define the true agent of ocular bacterial inflammation. Int J Immunopathol Pharmacol 2011; 24:285-96.
65. Demoulin JB, Louahed J, Dumoutier L, Stevens M, Renauld JC. MAP kinase activation by interleukin-9 in lymphoid and mast cell lines. Oncogene 2003; 22:1763-70. (Pubitemid 36513136)
66. Rossi A, Iorio A, Scali E, Fortuna MC, Mari E, Palese E, Greco P, Carlesimo M. Monilethrix treated with minoxidil. Int J Immunopathol Pharmacol 2011; 24(1):239-42.
67. Hossein-Nezhad A, Mirzaei K, Aslani S, Tootee A, Karimi F. MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. Eur J Inflamm 2011; 9:125-34.
68. Rigante D, Zampetti A, Bersani G, Candelli M, Piras A, Rendeli C, Antuzzi D, Feliciani C, Stabile A. Serum interleukin-18 in children with Henoch-Schönlein purpura: a promising marker of disease activity. Eur J Inflamm 2011; 9:157-168.
69. McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 2003; 100:7761-6. (Pubitemid 36760043)
70. Silambarasan G, Ramanathan T, Nabeel MA, Kalaichelvan VK, Kathiresan K, Balasubramanian T. Anti-inflammatory activity of the marine cyanobacterium trichodesmium erythraeum against carrageenan-induced paw oedema in wistar albino rats. Eur J Inflamm 2011; 9:53-56.
71. Soussi-Gounni A, Kontolemos M, Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 2001; 107:575-82. (Pubitemid 32397739)
72. Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis. Int J Immunopathol Pharmacol. 2011; 24(l):269-74.
73. De Amici M, Villani MA, Milanesi E, Rossini B, Barco S, Gerletti M, Ciprandi G. Adverse reactions to anaesthetics prevented by the use of specific laboratory tests Eur J Inflamm 2011; 9:79-81
74. Jones TG, Hallgren J, Humbles A, Burwell T, Finkelman FD, Alcaide P, Austen KF, Gurish MF. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol 2009; 183:5251-60.
75. Re M, Magliulo G, Tarchini P, Mallardi V, Rubini C, Santarelli A, Lo Muzio L. p53 and BCL-2 overexpression inversely correlates with histological differentiation in occupational ethmoidal intestinal-type sinonasal adenocarcinoma. Int J Immunopathol Pharmacol 2011; 24:603-9.
76. Tripodi D, D'Ercole S, Pasini M, Nastasio S, Bonini S, Giuca MR. Inflammatory and immunitary modifications in saliva of subjects with labial and tongue piercing. Eur J Inflamm 2011; 9:185-191.
77. Neill DR, McKenzie AN. TH9 cell generation. TH9: the latest addition to the expanding repertoire of IL-25 targets. Immunol Cell Biol 2010; 88:502-4.
78. Bruzzese V. Therapeutic effectiveness of minimal doses of rituximab in a patient with rheumatoid arthritis. Int J Immunopathol Pharmacol.2011; 24(1):265-7.
79. Guillén D, Millán O, Brunet M. In vitro studies of the immunomodulatory effects of statins alone and in combination with immunosuppressive drugs. Eur J Inflamm 2011; 9:117-124.
80. Noelle RJ, Nowak EC. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010; 10:683-7.
81. Arendse B, Van Snick J, Brombacher F. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses. J Immunol 2005; 174:2205-11. (Pubitemid 40223966)
82. Altorjay I, Veréb Z, Serfozo Z, et al. Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells. Int J Immunopathol Pharmacol 2011;24:323-35.
83. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R, Smith P, McKenzie AN. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17:7-17. (Pubitemid 34874614)
84. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol 2011; 186:3283-8.
85. Middleton Jr E, Kandaswami C, Theoharides TC.The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000; 52:673-751.